Tech Company Financing Transactions
Abilita Bio Funding Round
Abilita Bio closed a $7.5 million venture capital round on 2/21/2023. Investors included Two Bear Capital.
Transaction Overview
Company Name
Announced On
2/21/2023
Transaction Type
Venture Equity
Amount
$7,500,000
Round
Undisclosed
Investors
Two Bear Capital (Lead Investor) (Mike Goguen)
Proceeds Purpose
The funds will help propel the company's existing preclinical therapeutic programs, initiate efforts on additional targets, grow the team, and expand operations in San Diego.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6888 Nancy Ridge Dr
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Abilita Bio was founded in June 2014 and is a biotechnology company focused on enabling discovery and development of drugs targeting membrane proteins, including G Protein Coupled Receptors (GPCRs) and ion channels. We have established collaborations, and seek to expand collaborative research agreements with global pharmaceutical and biotechnology companies. We are currently incubating in JLabs San Diego (a life science innovation center operated by Janssen Research & Development).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mauro Mileni
Chief Financial Officer
James Schmidt
Chief Scientific Officer
Michael Hanson
Browse more venture capital transactions:
Prev: 2/21/2023: Paleo venture capital transaction
Next: 2/21/2023: Curio venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs